217 Evaluating biomarkers of JTX-8064 (anti-LILRB2/ILT4 monoclonal antibody) in an ex vivo human tumor histoculture system to inform clinical development

217 Evaluating biomarkers of JTX-8064 (anti-LILRB2/ILT4 monoclonal antibody) in an ex vivo human tumor histoculture system to inform clinical development

Bibliographic Details
Main Authors: Edward Stack, Jeff Smith, Yasmin Hashambhoy-Ramsay, Vikki Spaulding, Michelle Priess, Kristin O’Malley, Monica Gostissa, Margaret Willer, Ben Umiker, Donald Shaffer
Format: Article
Language:English
Published: BMJ Publishing Group 2020-11-01
Series:Journal for ImmunoTherapy of Cancer
id doaj-945c3ea2eb844800ad50a8f0bfc39d5e
record_format Article
spelling doaj-945c3ea2eb844800ad50a8f0bfc39d5e2020-12-11T10:00:51ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262020-11-018Suppl 310.1136/jitc-2020-SITC2020.0217217 Evaluating biomarkers of JTX-8064 (anti-LILRB2/ILT4 monoclonal antibody) in an ex vivo human tumor histoculture system to inform clinical developmentEdward Stack0Jeff Smith1Yasmin Hashambhoy-Ramsay2Vikki Spaulding3Michelle Priess4Kristin O’Malley5Monica Gostissa6Margaret Willer7Ben Umiker8Donald Shaffer9Jounce Therapeutics, Cambridge, MA, USAJounce Therapeutics, Cambridge, MA, USAJounce Therapeutics, Cambridge, MA, USAJounce Therapeutics, Cambridge, MA, USAJounce Therapeutics, Cambridge, MA, USAJounce Therapeutics, Cambridge, MA, USAJounce Therapeutics, Cambridge, MA, USAJounce Therapeutics, Cambridge, MA, USAJounce Therapeutics, Cambridge, MA, USAJounce Therapeutics, Cambridge, MA, USA
collection DOAJ
language English
format Article
sources DOAJ
author Edward Stack
Jeff Smith
Yasmin Hashambhoy-Ramsay
Vikki Spaulding
Michelle Priess
Kristin O’Malley
Monica Gostissa
Margaret Willer
Ben Umiker
Donald Shaffer
spellingShingle Edward Stack
Jeff Smith
Yasmin Hashambhoy-Ramsay
Vikki Spaulding
Michelle Priess
Kristin O’Malley
Monica Gostissa
Margaret Willer
Ben Umiker
Donald Shaffer
217 Evaluating biomarkers of JTX-8064 (anti-LILRB2/ILT4 monoclonal antibody) in an ex vivo human tumor histoculture system to inform clinical development
Journal for ImmunoTherapy of Cancer
author_facet Edward Stack
Jeff Smith
Yasmin Hashambhoy-Ramsay
Vikki Spaulding
Michelle Priess
Kristin O’Malley
Monica Gostissa
Margaret Willer
Ben Umiker
Donald Shaffer
author_sort Edward Stack
title 217 Evaluating biomarkers of JTX-8064 (anti-LILRB2/ILT4 monoclonal antibody) in an ex vivo human tumor histoculture system to inform clinical development
title_short 217 Evaluating biomarkers of JTX-8064 (anti-LILRB2/ILT4 monoclonal antibody) in an ex vivo human tumor histoculture system to inform clinical development
title_full 217 Evaluating biomarkers of JTX-8064 (anti-LILRB2/ILT4 monoclonal antibody) in an ex vivo human tumor histoculture system to inform clinical development
title_fullStr 217 Evaluating biomarkers of JTX-8064 (anti-LILRB2/ILT4 monoclonal antibody) in an ex vivo human tumor histoculture system to inform clinical development
title_full_unstemmed 217 Evaluating biomarkers of JTX-8064 (anti-LILRB2/ILT4 monoclonal antibody) in an ex vivo human tumor histoculture system to inform clinical development
title_sort 217 evaluating biomarkers of jtx-8064 (anti-lilrb2/ilt4 monoclonal antibody) in an ex vivo human tumor histoculture system to inform clinical development
publisher BMJ Publishing Group
series Journal for ImmunoTherapy of Cancer
issn 2051-1426
publishDate 2020-11-01
work_keys_str_mv AT edwardstack 217evaluatingbiomarkersofjtx8064antililrb2ilt4monoclonalantibodyinanexvivohumantumorhistoculturesystemtoinformclinicaldevelopment
AT jeffsmith 217evaluatingbiomarkersofjtx8064antililrb2ilt4monoclonalantibodyinanexvivohumantumorhistoculturesystemtoinformclinicaldevelopment
AT yasminhashambhoyramsay 217evaluatingbiomarkersofjtx8064antililrb2ilt4monoclonalantibodyinanexvivohumantumorhistoculturesystemtoinformclinicaldevelopment
AT vikkispaulding 217evaluatingbiomarkersofjtx8064antililrb2ilt4monoclonalantibodyinanexvivohumantumorhistoculturesystemtoinformclinicaldevelopment
AT michellepriess 217evaluatingbiomarkersofjtx8064antililrb2ilt4monoclonalantibodyinanexvivohumantumorhistoculturesystemtoinformclinicaldevelopment
AT kristinomalley 217evaluatingbiomarkersofjtx8064antililrb2ilt4monoclonalantibodyinanexvivohumantumorhistoculturesystemtoinformclinicaldevelopment
AT monicagostissa 217evaluatingbiomarkersofjtx8064antililrb2ilt4monoclonalantibodyinanexvivohumantumorhistoculturesystemtoinformclinicaldevelopment
AT margaretwiller 217evaluatingbiomarkersofjtx8064antililrb2ilt4monoclonalantibodyinanexvivohumantumorhistoculturesystemtoinformclinicaldevelopment
AT benumiker 217evaluatingbiomarkersofjtx8064antililrb2ilt4monoclonalantibodyinanexvivohumantumorhistoculturesystemtoinformclinicaldevelopment
AT donaldshaffer 217evaluatingbiomarkersofjtx8064antililrb2ilt4monoclonalantibodyinanexvivohumantumorhistoculturesystemtoinformclinicaldevelopment
_version_ 1724386690623078400

Similar Items